214 related articles for article (PubMed ID: 19756962)
21. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system.
Sanada S; Hakuno D; Higgins LJ; Schreiter ER; McKenzie AN; Lee RT
J Clin Invest; 2007 Jun; 117(6):1538-49. PubMed ID: 17492053
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-33 induces expression of adhesion molecules and inflammatory activation in human endothelial cells and in human atherosclerotic plaques.
Demyanets S; Konya V; Kastl SP; Kaun C; Rauscher S; Niessner A; Pentz R; Pfaffenberger S; Rychli K; Lemberger CE; de Martin R; Heinemann A; Huk I; Gröger M; Maurer G; Huber K; Wojta J
Arterioscler Thromb Vasc Biol; 2011 Sep; 31(9):2080-9. PubMed ID: 21737781
[TBL] [Abstract][Full Text] [Related]
23. ST2 Signaling in the Tumor Microenvironment.
Chang CP; Hu MH; Hsiao YP; Wang YC
Adv Exp Med Biol; 2020; 1240():83-93. PubMed ID: 32060890
[TBL] [Abstract][Full Text] [Related]
24. IL-33: a novel danger signal system in atopic dermatitis.
Cevikbas F; Steinhoff M
J Invest Dermatol; 2012 May; 132(5):1326-9. PubMed ID: 22499037
[TBL] [Abstract][Full Text] [Related]
25. The role of IL-33/ST2L signals in the immune cells.
Lu J; Kang J; Zhang C; Zhang X
Immunol Lett; 2015 Mar; 164(1):11-7. PubMed ID: 25662624
[TBL] [Abstract][Full Text] [Related]
26. IL-33/ST2 axis controls Th2/IL-31 and Th17 immune response in allergic airway diseases.
Vocca L; Di Sano C; Uasuf CG; Sala A; Riccobono L; Gangemi S; Albano GD; Bonanno A; Gagliardo R; Profita M
Immunobiology; 2015 Aug; 220(8):954-63. PubMed ID: 25747940
[TBL] [Abstract][Full Text] [Related]
27. Soluble ST2 protein inhibits LPS stimulation on monocyte-derived dendritic cells.
Nagata A; Takezako N; Tamemoto H; Ohto-Ozaki H; Ohta S; Tominaga S; Yanagisawa K
Cell Mol Immunol; 2012 Sep; 9(5):399-409. PubMed ID: 22922442
[TBL] [Abstract][Full Text] [Related]
28. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression.
Sweet MJ; Leung BP; Kang D; Sogaard M; Schulz K; Trajkovic V; Campbell CC; Xu D; Liew FY
J Immunol; 2001 Jun; 166(11):6633-9. PubMed ID: 11359817
[TBL] [Abstract][Full Text] [Related]
29. Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis.
Pastorelli L; Garg RR; Hoang SB; Spina L; Mattioli B; Scarpa M; Fiocchi C; Vecchi M; Pizarro TT
Proc Natl Acad Sci U S A; 2010 Apr; 107(17):8017-22. PubMed ID: 20385815
[TBL] [Abstract][Full Text] [Related]
30. IL-33 Receptor (ST2) Signalling is Important for Regulation of Th2-Mediated Airway Inflammation in a Murine Model of Acute Respiratory Syncytial Virus Infection.
Zeng S; Wu J; Liu J; Qi F; Liu B
Scand J Immunol; 2015 Jun; 81(6):494-501. PubMed ID: 25721734
[TBL] [Abstract][Full Text] [Related]
31. IL-33 Initiates Vascular Remodelling in Hypoxic Pulmonary Hypertension by up-Regulating HIF-1α and VEGF Expression in Vascular Endothelial Cells.
Liu J; Wang W; Wang L; Chen S; Tian B; Huang K; Corrigan CJ; Ying S; Wang W; Wang C
EBioMedicine; 2018 Jul; 33():196-210. PubMed ID: 29921553
[TBL] [Abstract][Full Text] [Related]
32. The IL-33/ST2 axis: Role in health and disease.
De la Fuente M; MacDonald TT; Hermoso MA
Cytokine Growth Factor Rev; 2015 Dec; 26(6):615-23. PubMed ID: 26271893
[TBL] [Abstract][Full Text] [Related]
33. The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33.
Palmer G; Lipsky BP; Smithgall MD; Meininger D; Siu S; Talabot-Ayer D; Gabay C; Smith DE
Cytokine; 2008 Jun; 42(3):358-64. PubMed ID: 18450470
[TBL] [Abstract][Full Text] [Related]
34. [Biological role of Interleukin 33 and its importance in pathophysiology of cardiovascular system].
Czyzewska-Buczyńska A; Zuk N; Romanowska-Micherda K; Witkiewicz W
Postepy Hig Med Dosw (Online); 2014; 68():834-41. PubMed ID: 24988604
[TBL] [Abstract][Full Text] [Related]
35. Structural insights into the interaction of IL-33 with its receptors.
Liu X; Hammel M; He Y; Tainer JA; Jeng US; Zhang L; Wang S; Wang X
Proc Natl Acad Sci U S A; 2013 Sep; 110(37):14918-23. PubMed ID: 23980170
[TBL] [Abstract][Full Text] [Related]
36. Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells.
Moulin D; Donzé O; Talabot-Ayer D; Mézin F; Palmer G; Gabay C
Cytokine; 2007 Dec; 40(3):216-25. PubMed ID: 18023358
[TBL] [Abstract][Full Text] [Related]
37. Expression of IL-33 and its receptor ST2 in chronic rhinosinusitis with nasal polyps.
Baba S; Kondo K; Kanaya K; Suzukawa K; Ushio M; Urata S; Asakage T; Kakigi A; Suzukawa M; Ohta K; Yamasoba T
Laryngoscope; 2014 Apr; 124(4):E115-22. PubMed ID: 24122812
[TBL] [Abstract][Full Text] [Related]
38. Characterization of signaling pathways activated by the interleukin 1 (IL-1) receptor homologue T1/ST2. A role for Jun N-terminal kinase in IL-4 induction.
Brint EK; Fitzgerald KA; Smith P; Coyle AJ; Gutierrez-Ramos JC; Fallon PG; O'Neill LA
J Biol Chem; 2002 Dec; 277(51):49205-11. PubMed ID: 12368275
[TBL] [Abstract][Full Text] [Related]
39. Conflicting vascular and metabolic impact of the IL-33/sST2 axis.
Altara R; Ghali R; Mallat Z; Cataliotti A; Booz GW; Zouein FA
Cardiovasc Res; 2018 Oct; 114(12):1578-1594. PubMed ID: 29982301
[TBL] [Abstract][Full Text] [Related]
40. Spinal interleukin-33 and its receptor ST2 contribute to bone cancer-induced pain in mice.
Zhao J; Zhang H; Liu SB; Han P; Hu S; Li Q; Wang ZF; Mao-Ying QL; Chen HM; Jiang JW; Wu GC; Mi WL; Wang YQ
Neuroscience; 2013 Dec; 253():172-82. PubMed ID: 23988433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
